Toluenediamine in polyurethane foams Hazard or artefact?
暂无分享,去创建一个
[1] H. F. Bushar,et al. A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants. , 1998, Environmental health perspectives.
[2] M. Cohen,et al. Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants. , 1997, Plastic and reconstructive surgery.
[3] M. Dalene,et al. Workers exposed to thermal degradation products of TDI- and MDI-based polyurethane: biomonitoring of 2,4-TDA, 2,6-TDA, and 4,4'-MDA in hydrolyzed urine and plasma. , 1997, American Industrial Hygiene Association journal.
[4] H. Tinnerberg,et al. Biomarkers in hydrolysed urine, plasma and erythrocytes among workers exposed to thermal degradation products from toluene diisocyanate foam. , 1997, The Analyst.
[5] L. Hagmar,et al. Toxicokinetics of 2,4- and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4- and 2,6- toluene diisocyanate. , 1996, Occupational and environmental medicine.
[6] T. Okumoto,et al. Effect of residual amine catalysis on the thermal degradation of polyurethane elastomers. , 1995 .
[7] K. White,et al. Characterization of polyesterurethane degradation products , 1994 .
[8] J. Wille,et al. Analysis of the extractive and hydrolytic behavior of microthane poly(ester-urethane) foam by high pressure liquid chromatography. , 1993, Journal of biomedical materials research.